Log In Get Started
Press Releases June 15, 2026 08:30 AM

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
IART

Integra LifeSciences Holdings Corporation announced that its executive vice president and president of Tissue Reconstruction, Bob Davis, will present at the 2026 Truist Securities MedTech Conference. The presentation will be webcast live, providing insight into the company's focused efforts in neurosurgery and tissue reconstruction sectors.

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
IART
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • The presentation highlights Integra LifeSciences' leadership in neurosurgery and tissue reconstruction medical technology.
  • It will showcase the company's specialized and innovative technologies that are trusted by healthcare professionals globally.
  • The live webcast offers investors and stakeholders direct access to leadership insights and strategic updates.

PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.

About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
[email protected]

Media Contact:
Laurene Isip
(609) 208-8121
[email protected]

Integra LifeSciences Holdings Corporation


Risks

  • Market reaction could be muted if no significant new information or guidance is provided during the presentation.
  • The medical technology sector faces regulatory and reimbursement uncertainties that could impact future performance.
  • Competition and innovation pace in medtech could affect Integra's market position and growth projections.

More from Press Releases

Roadzen Subsidiary drivebuddyAI Granted Patent for Real-Time Lane Detection System; Demonstrates Technology at InCabin Detroit 2026 Jun 15, 2026 Cycurion Responds to Coordinated Stock Attack While Strengthening Core Business Jun 15, 2026 Paychex Recognized as a Top WorkTech Company by TIME Jun 15, 2026 Edible Garden Issues Letter Encouraging Shareholders to Vote FOR All Proposals at June 17, 2026, Annual Meeting Jun 15, 2026 E-Power Inc. Secures RMB 3 Million Government Grant from Guizhou Provincial Big Data Bureau for AIoT and Blockchain-Driven Smart Manufacturing Platform in the Lithium Battery Anode Industry Jun 15, 2026